Press release
Pericarditis Market Estimation 2018 by Top Leading Players - Pfizer Inc. (U.S.), AstraZeneca (U.S.), Bayer AG (Europe), Reckitt Benckiser Group plc. (Europe), PerkinElmer, Inc. (U.S.) Outlook 2023 – MarketResearchFuture.com
Global Pericarditis Market -Synopsis
According to a new report by Market Research Future, the global market for pericarditis is estimated to expand at a striking 7.5% CAGR during the forecast period (2017-2023) due to the adoption and growing awareness of anti-inflammatory drugs. Pericarditis is a condition of irritation and swelling of the pericardium sac and can lead to heart palpitations and chest pain.
While acute pericarditis does not last long, chronic pericarditis lasts for weeks to months. Treatment might include medication and surgery in case of chronic pericarditis. According to the American Heart Association, the growing geriatric population is more susceptible to pericarditis.
Global Pericarditis Market -Drivers and Constraints Impacting the Growth
Increasing prevalence of cardiovascular diseases, growing geriatric population, and rising healthcare are some of the major factors driving the market growth for pericarditis globally. Several autoimmune diseases, rising cases of heart attack, changing lifestyle, rapid urbanization, advantages of botanical drugs over other drugs, treatment of illness, improvement in reimbursement policies, and several other are some of the push factors.
Moreover, the rapid industrialization, constant innovations, burgeoning demands, technological advancements, growth of the medical sector, and rise in expenditure in R&D are some of the other factors fueling the market growth during the assessment period. Also, concerned manufacturers are taking up joint ventures, partnerships, and acquisitions as their key policies which is further contributing to the inorganic growth of the market.
Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/1847
Global Pericarditis Market - Segmentation
The global pericarditis has been segmented on the basis of diagnosis, type, treatment, end-users, and region.
The market has been segmented into chronic, acute, recurrent pericarditis, and others based on type.
The market has been segmented into blood test, echocardiogram, electrocardiogram, X-ray, and others based on diagnosis. While the electro gram segment is subdivided into ECG, EKG, and others, the echocardiogram segment is subdivided into transesophageal echocardiogram, transthoracic echocardiogram, stress echocardiogram, and others.
The market has also been segmented into surgical, pharmacological, and others based on treatment. The pharmacological segment is sub-segmented into colchicine, non-steroidal anti-inflammatory drugs, and others. The non-steroidal anti-inflammatory is again sub-segmented into ibuprofen, aspirin, and others. Also, the surgical segment is subdivided into pericardiocentesis, pericardiectomy, pericardiotomy, and others. The market has been segmented into medical institutes, hospitals & clinics, research organization, and others.
Global Pericarditis Market -Competition Analysis
The prominent players operating the market for global pericarditis are
Pfizer Inc. (U.S.)
Reckitt Benckiser Group Plc. (Europe)
FUJIFILM Holdings Corporation (Asia Pacific)
Merck Sharp & Dohme Corp. (U.S.)
Bayer AG (Europe)
AstraZeneca (U.S.)
ALLERGAN (Europe)
PerkinElmer Inc. (U.S.)
Obtain Report Details with Technological Advancement @ https://www.marketresearchfuture.com/reports/pericarditis-market-1847
North America to Dominate the Market
Geographically, the market for pericarditis has been spanned across North America, Europe, Asia Pacific, and the Middle East and Africa. North America is anticipated to dominate the global market for pericarditis owing to the increasing patient population for cardiovascular diseases, rising healthcare expenditure, and growing geriatric population. According to Centers for Disease Control and Prevention, the total expenditure for health care in the U.S. accounted for 17.8 % of the total gross product.
Europe holds the second largest position and is closely followed by the Asia Pacific market. Growing expenditure for health care, availability of funds for R&D, and high patient population are some of the major drivers for this market in this region.
Global Pericarditis Market -Industry News
KEYTRUDA, Merck’s anti-PD-1 therapy had been approved by the China National Drug Administration for the treatment of patients suffering from metastatic melanoma or unrespectable, as declared by Kenilworth, known as MSD outside the US. This is the only and the first approval of anti-PD-1 therapy for advanced melanoma in the China region.
Major Points form Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Pericarditis Market, By Type
Chapter 7. Global Pericarditis Market, By Treatment
Chapter 8 Global Pericarditis Market, By End User
Chapter 9. Global Pericarditis Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/1847
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pericarditis Market Estimation 2018 by Top Leading Players - Pfizer Inc. (U.S.), AstraZeneca (U.S.), Bayer AG (Europe), Reckitt Benckiser Group plc. (Europe), PerkinElmer, Inc. (U.S.) Outlook 2023 – MarketResearchFuture.com here
News-ID: 1166138 • Views: …
More Releases from Market Research Future
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035.
Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial…
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035.
Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are…
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034.
Cheese packaging…
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by…
More Releases for Pericarditis
Top Trends Transforming the Pericarditis Market Landscape in 2025: Innovative Ad …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pericarditis Industry Market Size Be by 2025?
There has been a significant growth in the pericarditis market size in the past few years. The projection is that it will escalate from $2.32 billion in 2024 to $2.49 billion in 2025, registering a compound annual growth rate…
Rising Cardiovascular Disease Rates Fueling Growth In The Pericarditis Devices M …
What combination of drivers is leading to accelerated growth in the pericarditis market?
A surge in cardiovascular disease cases is poised to drive growth in the pericarditis market. Cardiovascular illnesses encompass a range of health conditions affecting the heart and blood vessels, which are often related to fatty deposit buildup within arteries and higher risk of blood clot formation. Untreated pericarditis may lead to cardiovascular diseases or even fatal outcomes in…
Global Pericarditis Market Size - By Product Type(Acute Pericarditis,Chronic Per …
Pericarditis Market Snapshot: Insight into Market Trends and Movements
Pericarditis is the inflammation of the pericardium, the fibrous sac surrounding the heart, often causing chest pain and discomfort.
The Pericarditis market is experiencing significant growth driven by rising incidences of heart-related disorders and advancements in diagnostic and therapeutic options. Increased awareness and improved access to heal are services are bolstering early diagnosis and treatment, propelling market expansion. Key players are focusing…
Pericarditis Market Report 2024-2033 | Size, Share And Insights
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Pericarditis Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.2 billion In 2028 At A…
Pericarditis Drugs Market Insights, Forecast to 2031 Kiniksa Pharmaceuticals, Pf …
A new Report by DataM Intelligence, titled "Pericarditis Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Pericarditis Drugs market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Pericarditis Drugs market has…
Pericarditis Treatment Market Key Manufacturers Analysis 2019 Industry Size by T …
Pericarditis is a cardiovascular disease which represents the swelling of the pericardium wall of the heart. The main cause of pericardium disease is the inflammation of pericardium wall which is generally caused by viral infection. Other causes of pericarditis disease are renal failure, bacterial infections and intake of some drugs such as procainamide.
Pericarditis Treatment Industry Scrutinized The increasing prevalence of cardiovascular diseases such as heart attack & hypertension, favorable reimbursement…
